Teva Pharmaceutical Industries (NYSE:TEVA) has seen its stock move steadily over the past month, gaining about 5%. Investors ...

Evaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining ...

Teva Pharmaceuticals USA, based in Parsippany, New Jersey, issued a voluntary recall on Oct. 7 for some of the prazosin ...

Key Points Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund ...

Explore how Teva Pharmaceutical (NYSE:TEVA) strengthens its global presence and influence in Healthcare Stocks worldwide.

Harel Insurance Investments & Financial Services Ltd. increased its Teva holding to 6.84% of its reportable U.S. equity ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of ...

Jefferies London Healthcare Conference Tuesday, November 18, 2025, at 11:00 A.M. Greenwich Mean Time (6:00 A.M. ET) To access a live webcast of the presentation, visit Teva’s Investor Relations ...

Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR asthma inhalers, ...

The main Irish arm of Israeli-headquartered pharmaceutical firm Teva last year paid out dividends of $709.5m (€617.9m). Teva firm Norton (Waterford) Ltd is one of the largest employers in the ...

Teva and Prestige announce a license and supply agreement for the commercialization of Prestige's Tuznue®, a biosimilar to Herceptin® (trastuzumab) Tuznue® received European Commission (EC) marketing ...